Zenflow

Palo Alto, United States Founded: 2014 • Age: 12 yrs
A device is developed to treat urinary obstruction from BPH.

About Zenflow

Zenflow is a Healthcare company based in Palo Alto (United States) founded in 2014 by Shreya Mehta. A device is developed to treat urinary obstruction from BPH. Zenflow has raised $100 million across 7 funding rounds from investors including NIH, Square 1 Bank and Cook Medical. The company has 25 employees. Its chief executive, as recorded, is Shreya Mehta. Zenflow offers products and services including Zenflow Procedure. Its focus areas include Life Sciences, Genitourinary Disorders, Medical Devices and Therapeutics. Its legal entity is Zenflow, Inc. Its competitors include Neotract, Urotronic and Rivermark; 3 of its 3 listed competitors have raised funding.

Company details

Zenflow was founded in 2014 in Palo Alto, United States, within the medical device sector focused on urology. A device called the Spring Implant is being developed to address urinary obstruction associated with benign prostatic hyperplasia. The procedure is designed for the prostatic urethra and completed in a 10-minute outpatient setting. Core operations involve device innovation for minimally invasive treatments in this field.

  • Headquarters Palo Alto, United States
  • Employees 25
  • Founders Shreya Mehta
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website zenflow.com
  • Social LinkedIn X Facebook
  • Legal Name Zenflow, Inc.
Operational Areas
Key Metrics
  • Total Equity Funding
    $100M (USD)

    in 7 rounds

  • Latest Funding Round
    $52M (USD), Series D

    Oct 2026

  • Investors
    NIH

    & 14 more

  • Employee Count
    25

Products & Services of Zenflow

Zenflow offers a comprehensive portfolio of products and services, including Zenflow Procedure.

Zenflow Procedure
Medical Treatment

Gentle, effective method for enlarged prostate relief with fast recovery and lasting benefits.

Funding Insights of Zenflow

Zenflow has successfully raised a total of $100M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $52 million completed in October 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $100M
  • Total Rounds 7
  • Last Round Series D β€” $52M
  • Investors Count 15

All 7 funding rounds of Zenflow with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2026$52MSeries D–Cook Medical
Nov 2024$24MSeries C––
Apr 2021$24MSeries B–Invus
Nov 2018$5MDebt – Conventional––
Feb 2018Grant––
Dec 2014Seed––
Jun 2014Grant––
Valuation history

15 investors in total: 15 institutional.

Investors in Zenflow

Zenflow has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, Square 1 Bank and Cook Medical.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Long-term private equity investments in transformational opportunities are pursued.
invus.comNew York, United States
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
fprimecapital.com
MedTech Venture Partners is focused on medical technology investments.
medtechvp.comMenlo Park, United States
Tech & Life-Sciences focused VC Firm investing in the US
goldenseeds.comNew York, United States
Early-stage startups are accelerated via funding and educational programs.
ycombinator.comMountain View, United States
Cloudstone Capital is engaged in venture capital investments focusing on healthtech.
2016cloudstonevc.comRedwood City, United States
invusopportunities.com
Venture debt, treasury, and cash management services are provided.
2005square1bank.comDurham, United States
Drug discovery services are provided to the biopharma sector.
1887nih.govUnited States
A government-backed foundation providing seed-stage investments to support small businesses.
1950nsf.govArlington, United States
Premium access

Investor details for Zenflow

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Zenflow

9 people are tracked at Zenflow (5 in leadership, 4 in team); the tracked headcount is 25.

NameRoleGroup
Shreya Mehta
ex-Co-Founder & CEOLeadership
Ronald Jabba
COOLeadership
Jamey Nielsen
Vice President Research And DevelopmentLeadership
Sierra Yearsley
Vice President Clinical AffairsLeadership
Jacob Graham
Director, QualityLeadership
Heber Saravia
Principal EngineerTeam
Fudda Ababseh
Clinical Research AssociateTeam
Mandy C.
Senior Research And Development EngineerTeam
Audra Loftman
Clinical Research ConsultantTeam
Premium access

Complete people profiles for Zenflow

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Zenflow

3 dated milestones of Zenflow across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Zenflow is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series D, of $52.0M.

Competitors of Zenflow

Zenflow has 3 listed competitors in our database, 3 of them funded. They include Neotract, Urotronic and Rivermark.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
neotract.com2004Mountain View, United States$137.96M119
Minimally invasive devices in urology
urotronic.com2015Plymouth, United States$47.05M18
Urethral stricture treatment devices are developed by Urotronic.
rivermarkmedical.com2021Milwaukee, United States$34.16M
Medical device for benign prostatic hyperplasia treatment is developed.
Premium access

Detailed competitors of Zenflow

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Zenflow

The website of Zenflow (zenflow.com) receives about 9.6K visits a month.

  • Monthly visits
    9.6K

    ▲ 145.4% vs previous month

Top companies in Genitourinary Disorders

3 companies that operate in the same segment as Zenflow (Genitourinary Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for drug-resistant bacterial infections are developed.
2013Cambridge, Massachusetts, United StatesUSD 114.7 MUSD 59.62 M32
Sacral neuromodulation devices are developed for urinary and bowel control.
2013Irvine, California, United StatesUSD 143.47 M
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction
2012Malvern, Pennsylvania, United StatesUSD 104.6 MUSD 80.28 M209
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Zenflow

Premium access

Complete news archive for Zenflow

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zenflow

Zenflow was founded in 2014.

Zenflow is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.

Shreya Mehta is the CEO of Zenflow, as recorded in our data. They have also founded this company.

Zenflow is a funded company, having raised a total of $100M across 7 funding rounds to date.

Zenflow has 25 employees.

Zenflow was founded in 2014 in Palo Alto, United States, within the medical device sector focused on urology. A device called the Spring Implant is being developed to address urinary obstruction associated with benign prostatic hyperplasia. The procedure is designed for the prostatic urethra and completed in a 10-minute outpatient setting. Core operations involve device innovation for minimally invasive treatments in this field.

Zenflow's top competitors include Neotract, Rivermark and Urotronic.

Zenflow offers Zenflow Procedure.

Zenflow has 15 investors. Key investors include NIH, Square 1 Bank, Cook Medical, Invus, and F-Prime Capital.

Zenflow operates through Zenflow, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available